» Articles » PMID: 24178791

Polycystic Ovary Syndrome: Perceptions and Attitudes of Women and Primary Health Care Physicians on Features of PCOS and Renaming the Syndrome

Overview
Specialty Endocrinology
Date 2013 Nov 2
PMID 24178791
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Polycystic ovary syndrome (PCOS) is an under-recognized, common, and complex endocrinopathy. The name PCOS is a misnomer, and there have been calls for a change to reflect the broader clinical syndrome.

Objective: The aim of the study was to determine perceptions held by women and primary health care physicians around key clinical features of PCOS and attitudes toward current and alternative names for the syndrome.

Design: We conducted a cross-sectional study utilizing a devised questionnaire.

Setting: Participants were recruited throughout Australia via professional associations, women's health organizations, and a PCOS support group.

Participants: Fifty-seven women with PCOS and 105 primary care physicians participated in the study.

Main Outcome Measures: Perceptions of key clinical PCOS features and attitudes toward current and alternative syndrome names were investigated.

Results: Irregular periods were identified as a key clinical feature of PCOS by 86% of the women with PCOS and 90% of the primary care physicians. In both groups, 60% also identified hormone imbalance as a key feature. Among women with PCOS, 47% incorrectly identified ovarian cysts as key, 48% felt the current name is confusing, and 51% supported a change. Most primary care physicians agreed that the name is confusing (74%) and needs changing (81%); however, opinions on specific alternative names were divided.

Conclusions: The name "polycystic ovary syndrome" is perceived as confusing, and there is general support for a change to reflect the broader clinical syndrome. Engagement of primary health care physicians and consumers is strongly recommended to ensure that an alternative name enhances understanding and recognition of the syndrome and its complex features.

Citing Articles

Integrated Transcriptome Analysis of lncRNA, miRNA, and mRNA Reveals key Regulatory Modules for Polycystic Ovary Syndrome.

Lin R, Zheng S, Su H, Wang G, Li X, Lu C Phenomics. 2025; 4(6):570-583.

PMID: 40061822 PMC: 11889321. DOI: 10.1007/s43657-024-00183-9.


The role of salivary antioxidant level in polycystic ovary syndrome women under assisted reproductive technology treatment: A case-control study.

Gholizadeh N, Koopaie M, Aleyasin A, Milani A, Aghahosseini M, Kharrazifard M Int J Reprod Biomed. 2025; 22(12):975-984.

PMID: 39968368 PMC: 11830924. DOI: 10.18502/ijrm.v22i12.18063.


Polycystic Ovarian Syndrome: A Review of Multi-omics Analyses.

Naqvi I, Bandyopadhyay A, Panda A, Hareramadas B Reprod Sci. 2025; 32(3):618-646.

PMID: 39875694 DOI: 10.1007/s43032-025-01789-8.


Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.

Taieb A, Asma G, Jabeur M, Fatma B, Nassim B, Asma B Clin Med Insights Endocrinol Diabetes. 2024; 17:11795514241296777.

PMID: 39494232 PMC: 11528641. DOI: 10.1177/11795514241296777.


Polycystic ovary syndrome and chronic pain among females and individuals of childbearing age: A scoping review.

Sacca L, Okwaraji G, Densley S, Marciniak A, Knecht M, Wilson C SAGE Open Med. 2024; 12:20503121241262158.

PMID: 38903491 PMC: 11189018. DOI: 10.1177/20503121241262158.